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The current study was aimed at (a) investigating the effect of three doses methylphenidate (MPH)
and placebo on inhibition of a prepotent response, inhibition of an ongoing response, and interfer-
ence control in Attention Deficit/Hyperactivity Disorder (AD/HD), and (b) studying dose-response
relations for the three forms of response inhibition. To meet these aims, the following tasks were
selected: two versions of the Stop Paradigm for inhibition of a prepotent response, a Circle Tracing
Task and a recently developed Follow Task for inhibition of an ongoing response, and the Stroop
Color-Word Test and an Eriksen Flanker Task for interference control. These tasks were adminis-
tered to 23 boys with AD/HD during four treatment conditions: 5 mg MPH, 10 mg MPH, 20 mg
MPH, and placebo. A pseudorandomized, multiple-blind, placebo-controlled, within-subject design
was used. As hypothesized, inhibitory control in children with AD/HD improved under MPH com-
pared to placebo. However, this effect was only significant for inhibition of a prepotent response and
inhibition of an ongoing response (as measured by the Follow Task), but not for interference control.
The relation between treatment condition and response was linear. However, this linear relation was
due to improved inhibitory control under MPH compared to placebo, because no effects of MPH dose
were observed for any of the response inhibition measures.
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INTRODUCTION
Attention Deficit/Hyperactivity Disorder (AD/HD)
is one of the most common child psychiatric disorders. In
the fourth edition of the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-IV; American Psychiatric
Association, 1994), three subtypes are distinguished, re-
flecting the possible combinations of the dimensions inat-
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tention and hyperactivity/impulsivity. Currently, the focus
of research is on the domain of impulsivity, which is usu-
ally defined as a lack of response inhibition (e.g., Barkley,
1997a; Halperin, McKay, Matier, & Sharma,
1994). Barkley (1997a, 1997b) suggested that behavioral
inhibition is the primary executive function (EF), nec-
essary to perform other EFs. According to Barkley, a
deficit in inhibition, which is seen as the core dysfunc-
tion in AD/HD, will lead to other EF problems. Penning-
ton and Ozonoff (1996) hypothesized that children with
AD/HD have a deficit in response inhibition, but not in
other EFs.
Barkley (1997a, 1997b) assumed that children with
AD/HD are deficient in three forms of inhibition:
(a) inhibition of a prepotent response, that is, a response
that is or has been previously associated with reinforce-
ment, (b) inhibition of an ongoing response (which allows
for a delay in the decision to continue responding), and
(c) interference control, that is, protecting a response from
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disruption by competing responses or events. The oper-
ationalization of these three forms of inhibition is not
clear (Nigg, 2001). For example, Barkley reported re-
sults obtained from studies of AD/HD children employing
the Stop Paradigm (see for review Oosterlaan, Logan, &
Sergeant, 1998) as evidence for a deficit in inhibition of
a prepotent response and in inhibition of an ongoing re-
sponse. Recently, Nigg (2000) proposed a taxonomy of
forms of inhibition in developmental psychopathology. In
this proposed taxonomy, inhibition of a prepotent response
(to be measured with the Stop Paradigm) is distinguish-
able from interference control (as measured by the Stroop
Color-Word Test and Flanker Task). Inhibition of an ongo-
ing response as defined by Barkley (1997a, 1997b) is not
included in the taxonomy proposed by Nigg (2000). Sug-
gested neural circuits in inhibition of a prepotent response
involve the lateral and orbital prefrontal cortex. A neural
system proposed to be crucial to interference control in-
volves the anterior cingulate, the dorsolateral prefrontal
cortex, and the basal ganglia.
Methylphenidate (MPH) is the most frequently pre-
scribed medication for children with AD/HD (Goldman,
Genel, Bezman, & Slanetz, 1998; Swanson, McBurnett,
Christian, & Wigal, 1995). It has been shown to reduce
symptoms of inattention, hyperactivity and impulsivity,
as observed by parents and/or teachers (e.g., MTA co-
operative group, 1999; Schachar & Tannock, 1993). Fur-
thermore, it has been demonstrated that MPH increases
performance on a variety of cognitive tasks (Rapport &
Kelly, 1991), including tasks measuring response inhibi-
tion (e.g., Tannock, Schachar, Carr, Chajczyk, & Logan,
1989; Tannock, Schachar, & Logan, 1995). Given the fact
that theories of impaired response inhibition are among the
most widely recognized ones in trying to understand the
main symptoms in children with AD/HD, it is surprising
that only a few studies have focused on the effect of MPH
on measures of response inhibition. A systematic analy-
sis of the effect of MPH on different forms of response
inhibition, as defined by Barkley (1997a, 1997b) has not
been conducted thus far. The current study was designed
to measure the effect of MPH on these three forms of
response inhibition.
Selected Tasks to Study Three Forms
of Response Inhibition
Inhibition of a Prepotent Response
The Stop Paradigm was used as a task to measure
inhibition of a prepotent response. Performing the Stop
Paradigm requires a subject to respond to a “go stimu-
lus.” However, occasionally, a stop signal is presented and
the prepotent response has to be inhibited. Two versions
of the Stop Paradigm, which both aim at estimating the
latency of the response inhibition process, were adminis-
tered: One with stop signals presented at fixed intervals,
and one applying a tracking mechanism to vary the interval
between the go and the stop signal (Logan, 1994; Logan,
Schachar, & Tannock, 1997; Osman, Kornblum, & Meyer,
1986). The Stop Paradigm with stop signals presented at
fixed intervals has been used frequently in research on
AD/HD (see for review Oosterlaan et al., 1998). However,
the Stop Paradigm with a tracking mechanism has several
advantages over the Stop Paradigm with stop signals pre-
sented at fixed delays (Band, van der Molen, & Logan, in
press). For example, it allows a more reliable estimate of
the latency of the response inhibition process (Stop Signal
Reaction Time [SSRT]), and a shorter test administration
than the version with stop signals presented at fixed de-
lays. The Stop Paradigm with a tracking mechanism has
been employed in a few studies of children with AD/HD
(Chhabildas, Pennington, & Willcutt, 2001; Nigg, 1999;
Schachar, Mota, Logan, Tannock, & Klim, 2000; Scheres,
Oosterlaan, & Sergeant, 2001a, 2001b). Although both
versions of the paradigm aim at estimating the latency of
the stop process (SSRT), it is not clear whether the two
versions yield similar SSRTs. In theory, the latency of the
stop process is constant. Thus, SSRTs in both versions of
the Stop Paradigm are expected to be identical. The two
versions of the Stop Paradigm have been compared in only
one study (Kooijmans, Scheres, & Oosterlaan, 2001), and
the tracking version of the Stop Paradigm has not been
used in evaluating the effect of medication. The current
study investigated whether both tasks are equally sensi-
tive to the effect of medication.
Inhibition of an Ongoing Response
A Circle Tracing Task (Bachorowski & Newman,
1985, 1990) and a recently developed Follow Task with
stop instructions (Morein-Zamir & Meiran, in press) were
used to measure inhibition of an ongoing response. Al-
though these tasks have not been used in research on
AD/HD previously, we selected these tasks because they
allow direct measurement of inhibition of an ongoing, or
continuous, response.
Interference Control
The Stroop Color-Word Test (Stroop, 1935) and the
Eriksen Flanker Task (Eriksen & Eriksen, 1974) were se-
lected to measure interference control. In both of these
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paradigms, a competing response to irrelevant information
has to be inhibited. However, in the Stroop Color-Word
Test, subjects have to suppress the response to a certain
stimulus feature, whereas in the Eriksen Flanker Task,
subjects have to suppress an automatic reading response
to irrelevant stimuli, flanking the target. The combination
of the Stroop Color-Word Test and an experimental task
such as the Eriksen Flanker Task to measure interference
control has been suggested by Nigg (2000).
Previous Research on Response Inhibition
and the Effects of MPH in Children With AD/HD
Inhibition of a Prepotent Response
In numerous studies, children with AD/HD have been
demonstrated to perform more poorly than normal chil-
dren on tasks measuring different forms of response inhi-
bition. Oosterlaan et al. (1998) performed a meta-analysis
on studies employing the Stop Paradigm with AD/HD
children. It was demonstrated that children with AD/HD
exhibit significantly slower response inhibition times
(SSRTs) than normal control children. Since that meta-
analysis, a number of studies have replicated this find-
ing (Chhabildas et al., 2001; Konrad, Gauggel, Manz, &
Scho¨ll, 2000; Nigg, 1999; Schachar et al., 2000; Solanto
et al., 2001; Wilcutt et al., 2001) although six other studies
have not differentiated AD/HD from control children on
this task (Kuntsi, Oosterlaan, & Stevenson, 2001;
Manassis, Tannock, & Barbosa, 2000; Pliszka, Liotti, &
Woldorff, 2000; Rubia et al., 2001; Scheres et al., 2001a,
2001b).
Only two studies (Tannock et al., 1989, 1995) have
investigated the effect of MPH on inhibition of a prepotent
response using the Stop Paradigm (Logan, 1994). Tannock
et al. (1989) showed that SSRT was significantly faster un-
der 1.0 mg/kg MPH compared to 0.3 mg/kg or placebo.
Subsequently, Tannock et al. (1995) investigated the dose-
response relation for response inhibition by studying the
effect of 0.3 mg/kg, 0.6 mg/kg, and 0.9 mg/kg MPH and
placebo on SSRT, and found an inverted U-shape relation.
The latter finding indicates that the effect of MPH on in-
hibition of a prepotent response did not increase linearly
with dose, but that the medium dose was the optimal one.
It is presently unclear whether the dose-response relation-
ship for other forms of inhibition are linear or have an
inverted U-shape in children with AD/HD.
Interference Control
Studies of interference control employing the Stroop
Color-Word Test are usually referred to as providing sup-
portive evidence for a difficulty in interference control
in children with AD/HD (e.g., Barkley, 1997a; Perugini,
Harvey, Lovejoy, Sandstrom, & Webb, 2000). In the
Stroop Color-Word Test, the color naming response has
to be protected from disruption by the automatic read-
ing response. Note that only a few studies found sig-
nificant group differences, when performance on the in-
terference condition was examined after controlling for
performance on the color naming condition (Carter,
Krener, Chaderjian, Northcutt, & Wolfe, 1995; Seidman,
Biederman, Mounteaux, Weber, & Faraone, 2000). One
study employing the Eriksen Flanker Task showed that
the AD/HD group was more distracted by incongruent
flankers as measured by hit rate (but not reaction times)
than the normal control group (Jonkman et al., 1999).
In the only published study on the effect of MPH on
interference control as measured by the Eriksen Flanker
Task in AD/HD (Jonkman et al., 1999), it was shown
that MPH did not reduce the interference problem in chil-
dren with AD/HD. Everett, Thomas, Cote, Levesque, and
Michaud (1991) studied hyperactive and normal children
and their interference control in the Stroop Color-Word
Test prior to a year of MPH treatment and after a year
of MPH treatment. Although hyperactive children’s per-
formance improved after MPH, they still performed more
poorly than normal controls.
Inhibition of an Ongoing Response
To date, inhibition of a continuous response as mea-
sured by the Circle Tracing Task and the Follow Task
has not been studied in children with AD/HD. However,
it has been shown that impulsive subjects are less able
to slow down while tracing a circle than normal con-
trols (Bachorowski & Newman, 1990). The relation be-
tween AD/HD and inhibition of an ongoing, continuous
response as measured by the Follow Task still has to be
established.
Aims
If a deficit in the three forms of response inhibition,
that is, inhibition of a prepotent response, inhibition of
an ongoing response, and interference control (Barkley,
1997a, 1997b) is the core problem in AD/HD leading
to other EF deficits and behavioral problems, it would
be of interest if MPH improves equally or differentially
these three forms of response inhibition. This was the
first aim of the current study. Secondly, because it is not
yet known whether dose-response relations are identical
for the three forms of response inhibition, dose response
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relations were studied for each form of inhibition in chil-
dren with AD/HD.
In order to address these issues, for each of the three
inhibition domains, two inhibition tasks were adminis-
tered to boys with AD/HD, under four treatment con-
ditions (placebo, 5 mg MPH, 10 mg MPH, 15/20 mg
MPH).
METHOD
Participants
Twenty-three boys with AD/HD in the age range
of 6–12 years (M D 8:7 years, SD D 1:7 years) partici-
pated in this study. Children were referred to pediatricians
and child psychiatrists at three clinics in The Netherlands.
These children were all identified as meeting the DSM-IV
criteria (APA, 1994) for AD/HD by the physician and/or
a multidisciplinary team of professionals and treatment
with MPH was suggested. The physician informed the par-
ents about the possibility of participating in a standardized
double-blind placebo-controlled evaluation procedure for
the effect of MPH. Parents and children received a let-
ter with information about the procedure and an informed
consent form. When parents and children agreed to par-
ticipate, they were invited to the first meeting (see below).
A medical ethics committee approved the study.
Selection Procedure
During the first meeting parents were adminis-
tered the Diagnostic Interview Schedule for Children
(DISC)-IV, parent version (Shaffer, Fisher, Lucas,
Dulcan, & Schwab-Stone, 2000). The DISC-IV is a struc-
tured interview that generates DSM-IV diagnoses. The fol-
lowing sections were administered: AD/HD, Oppositional
Defiant Disorder (ODD), and Conduct Disorder (CD).
In order to be diagnosed with AD/HD based on the
DISC-IV, the child had to demonstrate at least six symp-
toms of inattention and/or six symptoms of hyperactivity/
impulsivity. Furthermore, in order to meet the pervasive-
ness criterion, at least two symptoms of AD/HD had to be
observed at home and in school. Finally, the age of onset
had to be before seven. While the parents were being inter-
viewed, four subtests of the Revised Wechsler Intelligence
Scale for children (WISC-R) were administered to the
child to assess intelligence. These subtests were Vocabu-
lary, Arithmetic, Block Design, and Picture Arrangement.
The estimated IQ as obtained from these subtests corre-
lates r D :93–.95 with the full scale IQ (Groth-Marnat,
1997).
Only children who met the DSM-IV criteria for
AD/HD (DISC-IV) and had an IQ above 70 could enter
the study. Children not meeting these criteria were referred
back to the physician and received regular treatment. For
all children who were diagnosed AD/HD by their physi-
cian and/or multidisciplinary team and referred to the
study, the DISC-IV confirmed and sometimes refined the
DSM-IV diagnosis (in terms of establishing AD/HD sub-
types and comorbidity). Twenty-four children with
AD/HD were selected for the study and participated. Be-
cause only one child in the AD/HD group was a girl, she
was excluded from the sample.
The average IQ of the children was 97.6 (SD 14.7;
see Table I). One child dropped out of the study after the
interview, because parents withdrew consent. From the
DISC-IV, it was determined that one child met criteria
for AD/HD hyperactive/impulsive subtype, eight children
were of the inattentive subtype, and 14 children met cri-
teria for the combined subtype. Ten children (eight com-
bined subtype, one inattentive subtype, and one hyperac-
tive/impulsive subtype) also met criteria for a diagnosis
of ODD, and one child (inattentive subtype) met criteria
for CD. None of the children had been previously treated
with MPH or another stimulant medication. Children did
not receive any other form of treatment during the titration
stage.
Table I. Group Characteristics and Diagnostic Data
AD/HD (n D 23)
Measure M SD
Age 8.7 1.7
IQ 97.6 14.7
DBD parent (n D 22)
Inattentiona 19.3 3.6
Hyperactivity/impulsivitya 17.9 5.1
ODDa 11.0 4.9
CD 2.6 2.1
DBD teacher
Inattentiona 18.7 5.4
Hyperactivity/impulsivitya 16.1 7.3
ODD 8.8 5.9
CD (n D 22) 2.9 3.5
DSM-IV screener parent
AD/HD (n D 21)a 58.6 6.8
ODD (n D 21) 19.5 6.8
CD (n D 22) 40.8 5.8
DSM-IV screener teacher
AD/HDa 58.3 11.7
ODD (n D 22) 16.9 8.9
CD 40.4 10.0
Note. DBDD Disruptive Behavior Disorder rating scale; ODDD oppo-
sitional defiant disorder; CD D conduct disorder.
aAverage scale score is at or above the 95th percentile.
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Rating Scale Scores
Parents and teachers of the participants completed
the Disruptive Behavior Disorder Rating Scale (DBD;
Pelham, Gnagy, Greenslade, & Milich, 1992; Oosterlaan,
Scheres, Antrop, Roeyers, & Sergeant, 2000) and a
DSM-IV screener (Hartman et al., 2001). The DBD con-
sists of (a) two subscales composed of the DSM-IV
items for AD/HD, that is, an Inattention subscale and a
Hyperactivity/Impulsivity subscale, (b) a scale composed
of the DSM-IV items for ODD, and (c) a scale composed
of the DSM-IV items for CD. Items were rated on a scale
from zero to three.
As can be seen in Table I, the average scores on the
DBD Inattention subscale were in the clinical range (95th–
100th percentile). Scores ranged between 8 and 27. These
scores were expected on the basis of the DISC-IV, because
all boys (except one) met DSM-IV criteria for AD/HD inat-
tentive subtype or combined subtype. Average scores on
the Hyperactivity/Impulsivity subscale were in the clinical
range and varied between 3 and 27. This range of scores
indicates that some boys fell in the clinical range, but oth-
ers did not. This finding reflects that 15 boys met DSM-IV
criteria for hyperactivity/impulsivity. Average scores on
the parent DBD ODD scale were in the clinical range, but
average scores on the teacher DBD ODD scale were not in
the clinical range. Scores on the DBD ODD scales ranged
between 1 and 20. Average scores on the CD scales were
not in the clinical range and varied from 0 to 13. The range
of scores on the ODD and CD scales reflects that 11 boys
had comorbid ODD or CD.
The DSM-IV screener was developed to assess syn-
dromes of childhood psychopathology based on the
DSM-IV (Hartman et al., 2001). This screener was de-
veloped on the basis of results from a large-scale study
on the internal construct validity of DSM-IV based ques-
tionnaires. The results of psychometric analyses showed
that deductively derived questionnaires based on DSM-IV
had better internal construct validity than more traditional
questionnaires, such as the CBCL, which are developed
inductively. The screener contains 181 items, which are
grouped into seven scales. These seven scales are the fol-
Table II. Medication Design (mg Methylphenidate)
Saturday Sunday Monday Tuesday Wednesday Thursday Friday
Lead-in 0 5 10 20
Week A 0 0 0 5 10 20 0
Week B 5 5 5 10 20 0 5
Week C 10 10 10 20 0 5 10
Week D 20 20 20 0 5 10 20
lowing: (a) AD/HD, (b) ODD, (c) CD, (d) anxiety, (e) de-
pression, (f) Pervasive Developmental Disorder (PDD),
and (g) schizophrenia. Items were rated on a scale from
zero to three. Average scale scores on the AD/HD scale for
both the parent and the teacher questionnaire were above
the 95th percentile (see Table I). Scores on all other scales
were below the 95th percentile (data available from the
first author).
Titration Stage
Medication Design
A pseudo-randomized, multiple-blind, placebo-
controlled, within-subject design was used in which all
participants received each of four treatment conditions:
placebo, 5 mg of MPH, 10 mg of MPH, and 15/20 mg
of MPH (see Table II). A combination of absolute doses
and relative (mg/kg) doses was applied in this study. The
low and medium doses were 5 and 10 mg respectively
for each child. The high dose was 15 mg for boys with a
body weight below 22 kg, and 20 mg for boys with a body
weight of 22 kg or higher. This procedure ensured that the
highest dose never exceeded 0.9 mg per kg body weight.
All boys in the present study had a body weight higher
than 22 kg and therefore the highest dose administered in
this study was always 20 mg.
Each treatment condition was administered 7 days,
twice daily, at breakfast (around 7:30 a.m.) and at lunch
(around 12:30 a.m.). Within each week, all the four treat-
ment conditions were administered and ordered such that
one condition was never administered on two successive
schooldays. The highest dose was never administered the
day after placebo. After 4 weeks, each treatment condi-
tion had been administered on all days of the week, and the
treatment condition on a fixed day was different in each
week. This allowed for assessment of the child under the
four treatment conditions on a fixed weekday. The order
of the weeks (within which the treatment conditions are
fixed) differed for children, and was implemented using
a Latin square design (4 week orders were used: ABCD,
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BCDA, CDAB, and DABC). However, due to practical
constraints, the four orders were not exactly balanced
over the group. Therefore, each medication condition was
tested as to whether it was administered to an equal num-
ber of boys in each week. Chi-square tests for goodness
of fit showed that for each medication condition, the num-
ber of participants tested did not differ significantly across
weeks (´2s between 3.7 and 6.0, all p values> :10). The
titration procedure started with a lead-in. The lead-in con-
sisted of 4 days in which all the treatment conditions were
administered in an ascending order, starting with placebo
on the first day and ending with 20 mg on the fourth day
(see Table II). Each week at arrival for the assessment of
the child, parents were required to return empty medica-
tion boxes and blisters, and take home new tablets for the
coming week.
Medication and placebo were prepared by the hos-
pital pharmacy, and packed in identical tablets. Placebo
tablets contained only a base granulate. The MPH tablets
of 5 and 10 mg contained base granulate plus MPH granu-
late, and the tablets of 20 mg contained only MPH
granulate.
Tasks
Inhibition of a Prepotent Response
The Stop Paradigm. The Stop Paradigm (Logan,
1994; Logan & Cowan, 1984) has been used in numer-
ous studies on children with AD/HD in the age range
of 6–12 years (see for review, Oosterlaan et al., 1998).
The task involves two types of trials: go trials and stop
trials. Go trials consisted of cartoon airplanes presented
for a period of 1000 ms at the midpoint of the computer
screen. Immediately before the go stimulus onset, a fix-
ation point (500 ms in duration) appeared on the screen.
If the plane pointed to the right, subjects were required to
press the right response button. If the plane pointed to the
left, subjects were instructed to press the left button. The
inter-stimulus-interval (ISI) was 1,500 ms. The inter-trial-
interval was 3000 ms. Stop trials consisted of a go trial and
a stop signal (a 1000 Hz tone, 50 ms in duration), presented
through earphones. The stop signal was usually presented
shortly after the plane, but could also be presented concur-
rently with or shortly before the plane, depending on the
child’s performance (see below). Children were instructed
not to press either of the two buttons, when they heard the
tone. Seventy-five percent of the trials were go trials, and
25% were stop trials. The Stop Paradigm allows measure-
ment of both response execution (go trials) and response
inhibition (stop trials).
Trials were presented in blocks of 64 trials. Within
a block, the plane pointed equally often to the right or
to the left, and stop signals were balanced for right and
left go trials. Stop trials were presented randomly within
each block. A stop trial was always followed by a go
trial. However, to prevent children from expecting that
a stop trial would always be followed by a go trial, two
stop trials were presented in succession in each
block.
To ensure that the children were familiar with the
paradigm, the task commenced with two practice blocks.
In the first practice block only go trials were presented.
During practice of the go task, children were encouraged
with standardized instructions to respond as quickly and
as accurately as possible. In the second practice block,
25% of the trials were stop trials. During practice of the
stop task, children were instructed to work as quickly
and accurately as possible and to try to suppress their
response, when they heard the stop signal. After practice,
participants were administered four experimental blocks
of 64 trials.
The dependent variable that reflects the latency of
the inhibitory process is SSRT. SSRT cannot be observed,
because the response to a stop signal is a covert one. There-
fore, SSRT has to be estimated. This can be done using the
race model (Logan & Cowan, 1984). This model assumes
that the go process and the stop process are independent.
The go stimulus triggers the go process and the stop sig-
nal initiates the stop process. The process that finishes first
wins the race. If the go process wins the race, the response
is executed. If the stop process finishes first, the response
is inhibited. The outcome of the race depends on the speed
and the variability of the go process, the delay between go
stimulus and stop signal, and the speed and the variability
of the stop process.
In this study, two methods for estimating SSRT were
employed: a method using fixed intervals between the go
and the stop signal, and a method applying a tracking
mechanism to vary the interval between the go and the
stop signal.
In the Stop Paradigm, as it was originally developed
(Logan, 1994; Logan & Cowan, 1984), stop signals are
presented at predetermined (fixed) intervals before the
subject’s expected response. In this way, the ability to
inhibit a response at different points in the response exe-
cution process can be determined. The shorter the time in-
terval between the stop signal and the expected response,
the more difficult it becomes to inhibit the response. In
the current study, the interval was 50 ms, 200 ms, 350 ms,
or 500 ms with each interval occurring on 25% of the
stop trials. The following procedure was used to calculate
SSRT for the Stop Paradigm with stop signals presented
at fixed intervals. First, reaction times on go trials were
rank ordered on a time axis. Reaction times were ordered
from fastest to slowest. Second, the nth reaction time was
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picked, where n is defined by the product of the number
of reaction times in the distribution and the probability of
responding given a stop signal (or 1 minus the probabil-
ity of inhibition). For example, if there were 100 reaction
times in the distribution and the probability of responding
given a stop signal was .3, the nth reaction time would be
the 30th in the rank-ordered distribution. The nth reaction
time is an estimate of the time at which the stop process
runs to completion, relative to the onset of the go signal.
Third, the stop signal interval (the time interval between
the stop signal and the subject’s expected response) was
subtracted from the nth reaction time to estimate SSRT.
SSRT was calculated for each interval and then averaged.
The “fixed interval procedure” was adapted to allow
for a more direct observation of SSRT (Logan et al., 1997;
Osman et al., 1986). In the adapted procedure, a track-
ing mechanism was applied to vary the delay between
the onset of the go signal and the stop signal dynami-
cally, contingent on the subject’s performance. The use of
a tracking mechanism has several theoretical and practi-
cal advantages over the Stop Paradigm with stop signals
presented at fixed intervals (Band et al., in press). For the
Stop Paradigm with the tracking mechanism, SSRT can be
observed almost directly. In the current study, the initial
delay between go signal and stop signal was 250 ms. If
the child succeeded in inhibiting his or her response, the
delay on the next stop trial was increased by 50 ms. If the
child did not succeed in inhibiting, the delay on the next
stop trial was decreased by 50 ms. By using this track-
ing mechanism, it was established that a child has a 50%
chance of response inhibition. This means that on aver-
age, the go and the stop process finish at the same time. In
this way, the finishing time of the go process becomes an
estimate of the finishing time of the stop process. SSRT
can be calculated by subtracting the mean delay from the
mean go signal reaction time.
For both versions of the Stop Paradigm, SSRT was
the primary dependent variable, reflecting the latency of
the inhibition process. In addition to SSRT, the latency
and the variability of the response execution process were
obtained. These variables were mean reaction time on go
trials (MRT), and standard deviation of the reaction times
on go trials (SD). MRT and SD were calculated across
correct responses on go trials.
Inhibition of an Ongoing Response
Circle Tracing Task. The Circle Tracing Task is a
task that requires subjects to trace a large printed circle
with their index finger (Bachorowski & Newman, 1985,
1990). Although this task has not been used with chil-
dren previously, it is a very simple task, which can be
easily performed by children of 6 years of age. The circle
was 50.80 cm (20 in.) in diameter, drawn on a cardboard
square, and covered with Plexiglas. The circle had a small
line indicating the starting and the finishing point of the
tracing. The word START (in green ink) and STOP (in
red ink) were printed on either side of this line. The task
was administered under two conditions: first with neutral
instructions (“trace the circle”) followed by inhibition-
instructions (“trace the circle again, but this time as slowly
as you can”). A maximum of 12 min was allowed for
both tracing conditions. Participants were not informed
of this fact. The calculated inhibition variable was the
time used to trace the circle in the slow condition mi-
nus the tracing time in the neutral condition. This de-
pendent variable will be referred to as inhibition time.
The larger the inhibition time, the better a participant
is able to inhibit (slow down) the continuous tracing
response.
Follow Task. A Follow Task (Morein-Zamir &
Meiran, in press) has been developed recently to measure
inhibition of a continuous response. Because this task has
only been used with adults so far, we conducted a pilot
study with children in the age range of 6–12 years (data
available from the first author). The advantage of using
a continuous response that has to be inhibited is that it
enables direct observation of the SSRT (as opposed to
indirect calculation as in the Stop Paradigm). Another ad-
vantage is that the SSRT can be observed for each trial.
This procedure has not been previously carried out in stud-
ies on AD/HD.
Each trial began with the target (a green square) pre-
sented in the center of the screen. To start a trial, children
pressed the left button of the mouse. The target moved
randomly and children were instructed to follow it with
the mouse cursor. The time the target was displayed on
the screen for a given location along the trajectory (tar-
get speed) was set at 85 ms. This target speed was chosen
based on the pilot study in children mentioned above. After
a variable delay (ranging from 10 to 20 s with an average of
15 s) children heard a stop signal (a 1,000 Hz tone, 100 ms
in duration) which instructed them to stop their continu-
ous response immediately. Children were informed that,
in order for their stop response to be considered success-
ful, they had to refrain from moving the cursor until the
next target appeared on the screen. The program defined a
500 ms pause in moving the cursor as a complete stop. The
next trial started 4 s after the cursor had stopped moving
completely.
Trials were presented in blocks of 10 trials. To ensure
that the children were familiar with the procedure, the
task commenced with a practice block. During practice,
children were encouraged to follow the target very closely
and to stop immediately when they heard the tone. It was
emphasized that they should keep their hand completely
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still after the stop signal. After practice, participants were
administered four experimental blocks.
The dependent variable that reflects the latency of
the inhibitory process is SSRT. SSRT in this task can be
observed and was operationalized as follows: the time,
computed by an analysis program, when the initial signs
of stopping can be observed in the continuous following
performance. The procedure was as follows: after the stop
tone, the position of the cursor (two-dimensional spatial
coordinates) was measured as many times as possible in
batches of 20 ms. For each 20-ms period, the program
computed the average distance between the present cur-
sor position and the cursor position at which the stop sig-
nal was presented. This distance was plotted as a function
of time elapsed, since the stop tone was presented (units
of 20 ms). The function is first linear (indicating that the
child is moving the cursor at a constant speed), but would
then flatten out (indicating that the child had begun to
stop). A linear regression analysis was performed on the
first five measurements (first 100 ms) with the above de-
fined distance as dependent variable and time bin as the
independent variable. The resulting regression model was
used to predict the distance at measurement 6. In the next
iteration, the regression analysis included the first six mea-
surements, to predict the distance at measurement 7, until
the 105th observation was reached. This allowed 2,100 ms
for the subjects to inhibit their response. Stopping initia-
tion was defined as the point after which five consecutive
positive deviations with respect to the predicted distance
were identified. Five consecutive positive deviations were
selected as the criterion, because the probability of this oc-
curring by chance is 1/25, or 0.03, which converges with
conventional significance levels.
Interference Control
Stroop Color-Word Test. The Stroop Color-Word test
(Stroop, 1935; Dutch version: Hammes, 1971) is a task
that measures interference control (MacLeod, 1991). Be-
cause this test requires automatic reading skills, it was
only administered to children aged 8 and higher. The test
consists of three cards with 100 stimuli each, ordered in
10 rows and 10 columns. First, children were presented
with the word card, on which the names of the colors red,
green, yellow, and blue are printed in black in a random
order. Participants were instructed to read the words as
quickly as they could. Speed of reading was measured in
this condition. On the second card (the color card) colored
rectangles (red, yellow, blue, and green) were presented
in a random order. Children were instructed to name the
colors as quickly as possible. Speed of color naming was
measured with this card. On the third card (the color-word
card), children were presented with color words in a ran-
dom order. The color of the ink in which the word was
printed differed from the meaning of the word. For exam-
ple, the word green was printed in red ink. Children were
instructed to name the color of the ink and not to read the
word. To perform correctly on the last card, the automatic
reading response must be inhibited, while the color of the
ink is named. The main dependent variable in this task
was the interference score for time (IS time), calculated
by subtracting the speed of color naming (measured by
card 2) from the time needed to name the colors in the
interference condition (card 3).
Eriksen Flanker Task. In the Eriksen Flanker Task
(Eriksen & Eriksen, 1974), the ability to inhibit a response
to irrelevant, interfering stimuli is measured. Flanker tasks
have been used in children as young as 5 years of age (e.g.,
Ridderinkhof, van der Molen, Band, & Bashore, 1997).
During incongruent trials (target stimulus surrounded by
incongruent flankers), competing, incorrect responses
must be inhibited. Typically, incongruent trials induce
slower reaction times and more errors compared to con-
gruent trials (targets surrounded by congruent flankers;
Ridderinkhof et al., 1997). In the present study, an arrow
version of the flanker task was used. Target stimuli were
arrows pointing to the right or to the left, presented at the
center of the screen. The direction of the target arrow indi-
cated whether the child had to press the left or the right re-
sponse button. The target stimulus was surrounded by two
distracters on both sides (left and right). The distracters
were either arrows or rectangles. There were three types of
trials in this task: neutral, congruent, and incongruent. A
neutral trial consisted of the target arrow flanked by rect-
angles (DD>DD or DD<DD). A congruent trial con-
sisted of the target arrow flanked by arrows that pointed in
the same direction as the target (>>>>> or <<<<<).
An incongruent trial consisted of a target arrow flanked
by arrows pointing in the opposite direction to the target
(>><>> or <<><<). When responding to the incon-
gruent trials, a child was required to inhibit the response
to distracting, irrelevant stimuli.
The task commenced with four practice blocks of 45
trials (15 trials for each condition) each, followed by six
experimental blocks, consisting of 60 trials each (20 tri-
als for each condition). The three types of trials were
presented randomly within each block. A warning sig-
nal, consisting of a cross (500 ms in duration), preceded
the imperative stimulus (1,000 ms in duration). After the
stimulus, the screen turned blank for 1,500 ms. The inter-
trial-interval was 3,000 ms.
Before practice, children were encouraged with
standardized instructions to respond as quickly and as
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accurately as possible. Between blocks, in order to achieve
an optimal balance between speed and accuracy for every
child, instructions emphasized either speed or accuracy or
both, dependent on the child’s performance during the pre-
vious block: Children were encouraged (a) to work as fast
as possible,when the percentage of errors was between 0
and 5%, (b) to work as accurately as possible, when the
percentage of errors was higher than 10%, or (c) to work
as fast and accurately as possible, when the percentage of
errors was between 5 and 10%.
The dependent variables for this task were an inter-
ference score for mean reaction time (MRT on incongru-
ent trials minus MRT on congruent trials) and an inter-
ference score for number of errors (number of errors on
incongruent trials minus number of errors on congruent
trials).
Procedure
Parents were informed of the study by the child psy-
chiatrist or pediatrician. They were given an information
leaflet about the purpose and the procedures used in this
study. In addition, they received a letter with an informed
consent form. When parents had read the information
about the study and were willing to participate, they signed
and returned the informed consent form. Parents were in-
vited then for the first meeting. At any time during the
study, parents could withdraw their consent.
During the first meeting, parents were interviewed
and the child’s intelligence was assessed. During the titra-
tion stage, children’s inhibitory functioning was assessed
during each of the four treatment conditions. Assessment
took place on the same weekday once a week. Children
were assessed in the clinic during the afternoon. On ar-
rival, at 12:30 p.m., the coded tablet was administered and
the child had lunch. Since the behavioral effect of MPH
reaches a maximum between 1 and 2 hr after oral admin-
istration (Swanson et al., 1995), the assessment started ex-
actly 1 hr after drug/placebo administration. Testing lasted
between 2 and 3 hr. Hence, all testing was done between
1 and 4 hr after drug administration.
The order of the inhibition tasks was balanced over
the AD/HD group, to control for a fatigue effect and for
the peak time of MPH. Half of the AD/HD children per-
formed block A (Stop Paradigm – Circle Tracing Task –
Stop Paradigm) first, followed by block B (Eriksen Flanker
Task – Stroop Color-Word Test – Follow Task). The other
half of the group performed block B first, followed by
block A. A 10-min break was scheduled between the two
blocks. The order of the blocks was fixed within a subject
across the weeks. Within block A, the order of the Stop
Paradigm with stop signals presented at fixed intervals
and the Stop Paradigm with the tracking mechanism was
balanced across children, in order to be able to compare
performance on these two tasks.
Statistical Analyses
First, in order to study the effect of the three doses of
MPH and placebo on the three forms of response inhibi-
tion, the dependent variables of the different tasks were an-
alyzed with ANOVAs, with treatment condition (placebo,
5 mg, 10 mg, and 20 mg MPH) as within-subject factor
(four levels). If there was a main effect of treatment con-
dition, the shape of that effect was studied by applying
polynomial contrasts. Furthermore, if there was a main
effect of treatment condition, Helmert contrasts were per-
formed to compare the effect of placebo to the effect of
medication (average of the three doses MPH). Secondly,
to study the effect of MPH dose (5 mg, 10 mg, and 20 mg),
ANOVAs with dose as within-subject factor (three levels)
were performed. In case of a significant dose effect, the
shape of that effect was studied by applying polynomial
contrasts.
Missing Data
Some cases were excluded for the analyses of the in-
hibition measures, either because of missing data due to
technical problems or extreme scores (see Table III). In the
Stop Paradigm with the tracking mechanism, the data of
one boy were missing due to technical problems, and three
cases were excluded because of extreme scores: One child
showed an accuracy of 50% on go trials, one child showed
a percentage inhibition of 12.5%, and one child had a cal-
culated SSRT lower than 50 ms. In the Stop Paradigm with
stop signals presented at fixed intervals, one case was ex-
cluded because of a low accuracy on go trials (50%), and
one case was excluded because calculation of the SSRT
was not possible due to perfect accuracy on stop trials.
Data of one child were missing due to technical problems
for the Follow Task. One child was excluded because of
an extreme score for the analyses of the Circle Tracing
Task. In the Eriksen Flanker Task, data of one child were
missing due to technical problems, and one child was ex-
cluded because of an extreme score for the Eriksen Flanker
Task. Nineteen children were included for the analyses of
the Stroop Color-Word Test. Five children were younger
than 8 years and therefore did not have the required au-
tomatic reading skills necessary to perform the Stroop
Color-Word Test for the purpose of measuring interference
control.
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Table III. Group Means and Standard Deviations for Inhibition Measures in the Four Treatment Conditions (Placebo,
5 mg, 10 mg, or 20 mg Methylphenidate)
AD/HD
Placebo 5 mg 10 mg 20 mg
Measure M SD M SD M SD M SD
Inhibition of a prepotent responsea
SSRT fixed (n D 21)b 254.8 91.3 211.7 56.2 200.4 56.1 207.9 61.7
Percentage inhibition tracking (n D 19)c 48.6 1.5 50.1 1.3 49.9 1.9 50.3 1.5
SSRT tracking (n D 19)d 219.1 92.9 153.4 56.5 151.2 40.2 138.4 34.0
Inhibition of an ongoing response
Circle inhibition time (n D 22) 156.5 170.9 149.5 137.9 160.0 155.7 143.3 127.1
Follow SSRT (n D 22)b 285.5 59.5 255.2 51.0 257.8 43.0 252.4 43.0
Interference control
Stroop IS Time (n D 18) 60.8 44.1 42.6 21.2 52.5 29.6 41.3 19.9
Eriksen IS MRT (n D 21) 34.4 30.2 23.8 14.3 19.8 17.0 24.3 19.7
Eriksen IS Errors (n D 21) 5.8 6.0 4.2 6.1 3.8 5.3 4.5 3.9
Response execution
Mean reaction time fixed (n D 21)b 435.1 96.1 405.7 93.1 399.3 80.0 395.0 71.7
Variability in responding fixed (n D 21)d 109.0 39.6 82.0 29.3 72.7 25.6 69.4 21.7
Mean reaction time tracking (n D 19) 430.2 88.8 403.0 75.2 402.4 95.3 393.8 55.4
Variability in responding tracking (n D 19)d 108.5 42.4 78.0 29.5 76.7 30.7 67.4 24.0
Note. AD/HD D Attention Deficit/Hyperactivity Disorder; SSRT D stop signal reaction time; IS D interference score;
MRT D mean reaction time.
aTwo versions of the Stop Paradigm were applied: a version with fixed intervals between the stop tone and the expected reaction
time, and a version with a tracking mechanism that adjusts the delay between go stimulus and stop signal contingent on the
participant’s performance (for further details, see text).
bMain effect of treatment condition, fi < :05.
cMain effect of treatment condition, fi < :01.
d Main effect of treatment condition, fi < :001.
RESULTS
The group means and standard deviations on all the
inhibition tasks are presented in Table III and Fig. 1.
Inhibition of a Prepotent Response
Stop Paradigm With Stop Signals Presented
at Fixed Intervals
A main effect of treatment condition was found for
SSRT, F(3; 60) D 3:75; p < :05; ·2 D 0:16. The shape
of this effect was linear, F(1; 20) D 6:24; p < :05;
·2 D 0:24. A Helmert contrast showed that children exhib-
ited faster SSRTs, when administered MPH compared to
placebo, F(1; 20) D 7:10; p < :05; ·2 D 0:26. However,
no significant differences for SSRT were observed among
the three doses of MPH, F(2; 40) D 0:28, ns; ·2 D 0:01).
Stop Paradigm With the Tracking Mechanism
Over treatment conditions, the tracking mechanism
was successful. The percentage inhibition was close to
the expected 50%: 49.7%. Unexpectedly, there was an
effect of treatment condition on the percentage inhibition,
F(3; 54) D 4:34; p < :01; ·2 D 0:19. This effect was
linear, F(1; 18) D 9:35; p < :01; ·2 D 0:34. This linear
effect appeared to be due to a slightly higher percen-
tage inhibition under MPH (50.1%) compared to
placebo (48.6%), F(1; 18) D 11:66; p < :01; ·2 D 0:39.
Slight variations in the percentage inhibition for the med-
ication conditions and placebo do not pose a threat to
the validity of SSRT as measured by this task. The per-
centage inhibition did not differ across doses of MPH,
F(2; 36) D 0:32; ns; ·2 D 0:02. This means that the track-
ing algorithm ensured that children reached approximately
50% inhibition on the stop trials under each MPH
dose.
A main effect of treatment condition was found for
SSRT, F(3; 54) D 8:25; p < :001; ·2 D 0:31. This effect
was linear, F(1; 18) D 15:29; p D :001; ·2 D 0:46.
A Helmert contrast showed that MPH induced shorter
SSRTs than placebo, F(1; 18) D 11:31; p < :01; ·2 D
0:39. However, no significant differences for SSRT were
detected among the three doses of MPH, F(2; 36) D 0:94;
ns; ·2 D 0:05.
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Inhibition of an Ongoing Response
Circle Tracing Task
No effect of treatment condition was observed for
the inhibition time as measured by the Circle Tracing
Task, F(3; 63) D 0:16; ns; ·2 < 0:01, or dose, F(2; 42) D
0:26; ns; ·2 D 0:01. Note that the scatter was large in this
task.
Follow Task
A significant effect of treatment condition was found
for SSRT as measured by the Follow Task, F(3; 63) D
3:04, p < :05; ·2 D 0:22. This effect was linear,
F(1; 21) D 5:76; p < :05; ·2 D 0:22. SSRTs were faster
under MPH compared to placebo, F(1; 21) D 6:19; p <
:05; ·2 D 0:23. No differences for SSRT were detected
across the three doses of MPH, F(2; 42) D 0:12; ns; ·2 <
0:01.
Interference Control
Stroop Color-Word Test
The effect of treatment condition on the interference
score for time was not statistically significant, F(3; 51) D
2:36; p D :08; ·2 D 0:12. No significant main effect of
dose was observed on the interference score for time,
F(2; 34) D 1:93; ns; ·2 D 0:10.
Eriksen Flanker Task
The task manipulation was effective. A main
effect of trial type (congruent vs. incongruent) was
observed for MRT, F(1; 20) D 70:17; p < :001; ·2 D
0:78, and for number of errors, F(1; 20) D 38:92; p <
:001; ·2 D 0:66. Compared to congruent trials, incongru-
ent trials led to slower reaction times and more
errors.
The effect of treatment condition on the interfer-
ence score for MRT failed to reach statistical significance,
F(3; 60) D 2:40; p D :08; ·2 D 0:11. No effect of dose
was found for the interference score for MRT, F(2; 40) D
0:52; ns; ·2 D 0:03. No effect of treatment condition was
observed for the interference score for number of errors,
F(3; 60) D 0:67; ns; ·2 D 0:03, nor was there an effect of
dose, F(2; 40) D 0:10; ns; ·2 < 0:01.
Response Execution Measures
In the two versions of the Stop Paradigm, measures
of response execution were obtained in addition to the
measures of response inhibition.
Stop Paradigm With Stop Signals Presented
at Fixed Intervals
A main effect of treatment condition was found
for the response execution measures MRT and variability
of reaction times, F(3; 60) D 3:22; p < :05; ·2 D
0:14; F(3; 60) D 18:29; p < :001; ·2 D 0:48, respecti-
vely. This effect was linear for both variables, F(1; 20) D
5:80; p < :05; ·2 D 0:23; F(1; 20) D 37:00; p < :001;
·2 D 0:65, respectively. A Helmert contrast showed
that children exhibited faster MRTs, F(1; 20) D 4:24;
p D :05; ·2 D 0:17, with smaller variability in respond-
ing, F(1; 20) D 28:86; p < :001; ·2 D 0:59, when admi-
nistered MPH compared to placebo. No significant effect
of dose was found for MRT, F(2; 40) D 0:66; ns; ·2 D
0:03. There was a significant effect of dose for variabil-
ity in responding, F(2; 40) D 3:81; p < :05; ·2 D 0:16.
This effect was linear, F(1; 20) D 5:30; p < :05; ·2 D
0:21.
Stop Paradigm With the Tracking Mechanism
For MRT, the effect of treatment condition fell short
of significance, F(3; 54) D 2:68; p D :06; ·2 D 0:13. A
significant effect of treatment condition was found for
variability in responding, F(3; 54) D 12:25; p < :001;
·2 D 0:41. This effect was linear, F(1; 18) D 18:31; p <
:001; ·2 D 0:50. A Helmert contrast showed that MPH in-
duced less variability in responding compared with
placebo, F(1; 18) D 23:34; p < :001; ·2 D 0:57. No sig-
nificant effect of dose was found for MRT, F(2; 36) D
0:29; ns; ·2 D 0:02, or for variability in responding,
F(2; 36) D 1:67; ns; ·2 D 0:09.
DISCUSSION
First, the findings of the current study indicate that
there was a main effect of treatment condition (placebo,
5 mg, 10 mg, 20 mg MPH) on inhibitory control in boys
with AD/HD. This effect was observed for inhibition of
a prepotent response, and for inhibition of an ongoing
response, but not for interference control. Furthermore,
it was observed for only one of the two measures for
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inhibition of an ongoing response. Generally, the effect
of treatment condition was linear. Secondly, no effect of
MPH dose (5 mg, 10 mg, 20 mg) on inhibition in children
with AD/HD was observed. Therefore, the linear effect of
treatment condition on inhibitory performance could be
attributed largely to differences in inhibitory performance
under MPH, on the one hand, and under placebo, on the
other.
The finding of improved inhibition of a prepotent
response in AD/HD children under MPH compared to
placebo measured by SSRT in the Stop Paradigm is con-
sistent with previous findings (Tannock et al., 1989, 1995).
In those studies, MPH speeded up SSRTs as measured with
the Stop Paradigm with stop signals presented at fixed in-
tervals. In the current study, this finding was replicated,
and extended for both versions of the Stop Paradigm.
However, the inverted U-shaped dose-response relation re-
ported by Tannock et al. (1995) in their second study was
not replicated in the current study. One explanation for this
discrepancy between studies could be due to differences
in the dose regimen employed. Tannock and colleagues
used relative doses of 0.3 mg/kg body weight as a low
dose, 0.6 mg/kg body as a medium dose, and 0.9 mg/kg
as a high dose. In our study, absolute doses of MPH were
used: 5 mg as a low dose, 10 mg as a medium dose, and
20 mg as a high dose. The absolute high dose in the current
study may have been lower than the absolute high dose in
Tannock et al.’s study.
The Stop Paradigm with stop signals presented at
fixed intervals and the Stop Paradigm with the tracking
mechanism yielded comparable medication effects. This
supports the convergence between these two versions of
the Stop Paradigm. Note, however, that the size of the med-
ication effect was larger for the paradigm with tracking
mechanism (·2 D 0:41) than for the version with fixed in-
tervals (·2 D 0:28). This suggests that the Stop Paradigm
with the tracking mechanism is more sensitive to the ef-
fect of medication than the paradigm with fixed intervals.
A second difference between the two versions of the Stop
Paradigm was observed: SSRTs in the Stop Paradigm with
the tracking mechanism were faster than SSRTs in the Stop
Paradigm with stop signals presented at fixed intervals (see
Table III). In a previous study in which these two versions
of the Stop Paradigm were used, the Stop Paradigm with
a tracking mechanism also yielded faster SSRTs than the
Stop Paradigm with stop signals presented at fixed inter-
vals (Kooijmans et al., 2001). In theory, the latency of the
stop process is constant. Thus, SSRTs in both versions of
the Stop Paradigm were expected to be identical. Band
et al. (in press), however, showed that SSRT is most re-
liably estimated when the percentage inhibition is 50%.
In the Stop Paradigm with stop signals presented at fixed
intervals, the percentage inhibition differs for the four in-
tervals, and the average percentage inhibition is not nec-
essarily 50%. Usually, SSRTs are underestimated when
the percentage inhibition is lower than 50% and overesti-
mated when the percentage inhibition is higher than 50%
(Band et al., in press). When the percentage inhibition in
the placebo condition was averaged over the four intervals,
it appeared to be 66.26%. Therefore, SSRT was possibly
overestimated in the Stop Paradigm with stop signals pre-
sented at fixed intervals.
In order to investigate this possibility, for the Stop
Paradigm with stop signals presented at fixed intervals,
SSRT was estimated for the point in the inhibition curve
at which percentage inhibition was 50% in the placebo
condition. This yielded an average SSRT of 199.3 ms,
which is shorter than the SSRT averaged over the four
intervals in the placebo condition (254.8 ms), and closer
to the SSRT in the Stop Paradigm with the tracking mech-
anism in the placebo condition (219.1 ms; data available
from the first author). These results suggest that SSRTs
were not entirely similar for the two versions of the Stop
Paradigm because SSRT was overestimated in the Stop
Paradigm with stop signals presented at fixed intervals.
Future work on these features of the two versions of the
Stop Paradigm is recommended.
In requiring inhibition of an ongoing response, a sig-
nificant effect of treatment condition was observed for the
Follow Task, but not for the Circle Tracing Task. In the
Follow Task, SSRT can be observed directly, as opposed
to the Stop Paradigm, in which SSRT has to be estimated.
This direct measure of inhibition of an ongoing response
provided a clear effect of MPH compared to placebo. Sim-
ilar to the findings obtained by the two versions of the Stop
Paradigm, no effect of MPH dose was observed. The lack
of treatment effect on the Circle Tracing Task could be due
to the large differences in inhibition times between chil-
dren in all treatment conditions. Inhibition times ranged
from 5 to 700 s.
With respect to the domain of interference control,
the interference score for number of errors in the Eriksen
Flanker Paradigm did not change under MPH compared
to placebo. Although children showed lower interference
scores for MRT under MPH compared to placebo, this ef-
fect fell short of statistical significance. In another study
on the effect of 15 mg MPH and placebo on the Eriksen
Flanker Task in AD/HD, no significant effect of MPH on
interference control was reported either (Jonkman et al.,
1999). On the second task measuring interference control,
the Stroop Color-Word Test, children showed a decrease in
the interference effect for time, when on MPH compared
P1: ZBU
Journal of Abnormal Child Psychology pp707-jacp-457111 December 13, 2002 9:51 Style file version May 30th, 2002
118 Scheres, Oosterlaan, Swanson, Morein-Zamir, Meiran, Schut, Vlasveld, and Sergeant
to placebo, but also here, the effect was nonsignificant. In
other studies employing the Stroop Color-Word Test, an
effect of MPH on Stroop performance has been reported.
For example, Everett et al. (1991) reported an improve-
ment on the interference score after 1 year of MPH treat-
ment, compared to a pretreatment baseline assessment. In
the current study, measures of interference control did not
prove sensitive to the effect of medication in AD/HD.
The fact that MPH had a positive effect on inhibi-
tion of a prepotent response and inhibition of an ongoing
response but not on interference control, has theoretical
implications. First, it could be interpreted as support for
the distinctiveness of interference control on the one hand,
and the two other types of response inhibition on the other.
Secondly, it may call into question the supposed deficit in
interference control in AD/HD: If MPH improves symp-
toms in AD/HD children but not their performance on
tasks measuring interference control, the primacy of an
interference control deficit may be called into question.
In the two domains of inhibition where a significant
effect of treatment condition was found (inhibition of a
prepotent response and inhibition of an ongoing response),
the shape of this effect was consistently linear. Note that
this linear effect was due to better inhibitory control under
MPH, compared to placebo, but not because of an effect
of MPH dose. On the basis of current findings, it cannot be
concluded that a low, medium, or a high dose is more effec-
tive than any other dose in improving inhibitory control in
boys with AD/HD. However, Tannock et al. (1995) found
a decrement in inhibitory performance with the high dose
compared to the medium dose. Also other studies have
reported an optimal response to medium or high doses
of MPH in cognitive tasks (e.g., Douglas, Barr, Amin,
O’Neill, & Britton, 1988; Sprague & Sleator, 1977). But
in a review of 13 studies in which the effect of low and high
doses of MPH on cognitive tasks were reported, no evi-
dence was found to support the position that performance
is optimal at a low dose compared to a high dose (Rapport
& Kelly, 1991). In 38.5% of the tasks, a dose effect was
found in favor of the high dose. However, for an equal
percentage of tasks, no dose effect was found at all. The
latter finding suggests that the current study is not the first
one failing to find dose effects for cognitive tasks. Van der
Meere, Gunning, and Stemerdink (1999) found neither an
effect of MPH on inhibitory performance as measured in
a go/no go test, nor a dose effect in AD/HD children. Sim-
ilarly, O’Toole, Abramowitz, Morris, and Dulcan (1997)
found no effect of MPH dose on impulsive responding
as measured by errors of commission on a Continuous
Performance Task.
Although the focus of the current study was on the
effect of MPH on response inhibition in AD/HD, in the
two versions of the Stop Paradigm measuring inhibition
of a prepotent response, two measures of response execu-
tion (MRT and variability in responding) were obtained in
addition to SSRT. Analyses showed that MPH improved
not only inhibitory control, but also speed (in one version)
and variability of the response execution process (in both
versions), thus confirming the generalized effect of MPH
as predicted by the cognitive–energetic model (Sergeant,
Oosterlaan, & Van der Meere, 1999; Sergeant & Van der
Meere, 2000). Furthermore, it was observed that the ef-
fect of MPH on variability in responding was larger than
the effect of MPH on inhibitory control or speed of the re-
sponse execution process. Moreover, a dose effect was ob-
served for variability in responding in the Stop Paradigm
with stop signals presented at fixed intervals. This was
the only variable for which an effect of MPH dose was
shown. These findings suggest that the effect of MPH is
not specifically related to the domain of inhibition. These
findings are of interest in that the variability in responding
has been shown to be the variable with the highest heri-
tability effect for AD/HD (Kuntsi et al., 2001). The current
results show that variability in responding may be more
sensitive to the effect of MPH than measures of response
inhibition.
The current study included children with AD/HD of
any subtype. However, Barkley’s (1997a, 1997b) disinhi-
bition hypothesis applies to the combined and the hyper-
active/impulsive subtypes of AD/HD only, and not to the
inattentive subtype. Little research has focused on possible
differences between AD/HD subtypes in their response to
MPH. There is some suggestion that children with only at-
tention problems respond optimally to low and moderate
doses, whereas children with the combined subtype re-
spond optimally to moderate and high doses (McBurnett,
2000). However, because of power constraints, children
with different subtypes of AD/HD were not compared
with one another on their response to MPH in the current
study. Future research is needed to show whether the ef-
fect of MPH on response inhibition may be different for
children with different subtypes of AD/HD.
In sum, current findings showed that MPH improved
inhibitory performance in two out of three domains of in-
hibition under study in boys with AD/HD. However, the
measures of interference control and the Circle Tracing
Task were not sensitive to the effect of MPH. Generally,
treatment condition–response relations were linear. These
linear relations were due to better inhibitory control under
MPH compared to placebo, and not because of an effect of
MPH dose on inhibitory performance. Finally, this study
showed that the Stop Paradigm with the tracking mech-
anism is more sensitive to MPH effects than the Stop
Paradigm with stop signals presented at fixed intervals,
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and that MPH not only improved inhibitory control in
AD/HD, but also reduced reaction times and variability in
responding.
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